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Abstract
People are constantly exposed to a wide variety of chemicals. Some of these compounds, such
as parabens, bisphenols and phthalates, are known to have endocrine disrupting potencies.
Over the years, these endocrine disrupting chemicals (EDCs) have been a rising cause for con-
cern. In this study, we describe setup and validation of two methods to measure EDCs in human
urine, using ultra-performance liquid chromatography tandem mass spectrometry. The phenol
method determines methyl-, ethyl-, propyl-, n-butyl- and benzylparaben and bisphenol A, F and
S. The phthalate method determines in total 13 metabolites of dimethyl, diethyl, diisobutyl, di-
n-butyl, di(2-ethylhexyl), butylbenzyl, diiso-nonyl and diisodecyl phthalate. Runtime was 7 and
8min per sample for phenols and phthalates, respectively. The methods were validated by the
National Institute of Standards & Technology (NIST) for 13 compounds. In addition, EDCs were
measured in forty 24-h urine samples, of which 12 EDCs were compared with the same samples
measured in an established facility (Rigshospitalet, Copenhagen, Denmark). The intra-assay
coefficient of variability (CV) was highest at 10% and inter-assay CV was highest at 12%.
Recoveries ranged from 86 to 115%. The limit of detection ranged from 0.06 to 0.43 ng/mL. Of
21 compounds, 10 were detected above limit of detection in ≥93% of the samples. Eight com-
pounds were in accordance to NIST reference concentrations. Differences in intercept were
found for two compounds whereas slope differed for six compounds between our method and
that used in the Danish facility. In conclusion, we set up and validated two high-throughput
methods with very short runtime capable of measuring 5 parabens, 3 bisphenols and 13 differ-
ent metabolites of 8 phthalates. Sensitivity of the phenol method was increased by using
ammonium fluoride in the mobile phase.
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Introduction
In daily life, people are constantly exposed to a wide variety of
exogenous substances. Parabens are used as preservatives in cos-
metics, creams, shampoos, pharmaceuticals and food. Bisphenol A
(BPA) is a widely used high-production-volume chemical and is used
in polycarbonate plastics and epoxy resins (1). Phthalate diesters are
used as plasticizers and solvents in, e.g., cosmetics, printing inks,
coatings of pharmaceuticals, cookware and food wrappers.
Exposure to these compounds occurs through ingestion, dermal con-
tact, inhalation and perinatal transmission (i.e., via placenta or
breast milk) of every-day products (2–5). The general population liv-
ing in the Western world is widely exposed to these chemicals (6–9).
Yet, individuals who occupationally use these products are reported
to be exposed to even higher concentrations (10). Still little is known
about human exposure to the BPA analogs bisphenol F (BPF) and
bisphenol S (BPS), which have been introduced to the market only
recently (11–13). These chemicals are increasingly used as replace-
ment of BPA, and are found in personal care products, food and
paper (14–16).
Parabens, bisphenols and phthalates are endocrine disrupting
chemicals (EDCs) (6, 17). Accumulating evidence supports the
potency of these EDCs to interfere with various physiological pro-
cesses including reproductive, metabolic and brain functions, and
they are linked to multiple health complications and diseases (18–
20). Due to observations on the adverse health effects of BPA, new
BPA analogs such as BPF and BPS have been introduced as pre-
sumed safe replacements. Yet recent studies have shown that BPF
and BPS may have an even stronger endocrine disrupting potency
than BPA (21, 22).
While exposure to one EDC may be worrisome, people are in
fact daily exposed to a complex mixture of chemicals. This means
that exposure to multiple EDCs should be assessed at the same time
(23, 24), which can be an analytical challenge. EDCs can be mea-
sured in urine by several different methods. The commonly used gas
chromatography combined with mass spectrometry (GC–MS) often
requires a derivatization step for sample volatility. Therefore, liquid
chromatography tandem mass spectrometry (LC–MS-MS) is pre-
ferred, as this technique can measure multiple analytes without fur-
ther derivations. Human exposure to these EDCs is often analyzed
in urine samples, which is relatively easy to collect, non-invasive and
available in large quantities and, thus, represents a biological matrix
suitable for large epidemiological and human biomonitoring studies.
In this study, we used ultra-performance LC–MS-MS to improve
runtime in two separate high-throughput isotope diluted methods,
one for the simultaneous measurement of five parabens and three
bisphenols, and the second method for measurement of 13 relevant
metabolites of 8 different phthalate diesters. The methods were val-
idated by comparison of data analyzed by classical LC–MS-MS
methods.
Materials and Methods
Sample collection and preparation
Forty non-diabetic Dutch adults (37–59 years) were obtained from
the Lifelines cohort study with available 24 h urine samples, as
described in details elsewhere (25). The Lifelines study is a large
population-based prospective study conducted in and representative
for the north of the Netherlands (26, 27). Urine samples were col-
lected between September 2008 and November 2010 from partici-
pants and stored at −80°C until analysis. The study protocol was
approved by the medical ethics committee of the University Medical
Center Groningen, and all participants provided written informed
consent (26).
Materials
Five parabens, 3 bisphenols and 13 metabolites of 8 different phthalate
diesters and their respective deuterated analogs were used as calibration
material and internal standard (Table I). EtP, n-PrP, BzP and deuter-
ated analogs of EtP (d4), n-PrP (d4), BzP (d7), MnHP (d4) and MiBP
(d4) were purchased from Toronto Research Chemicals (Toronto,
Canada). MeP, n-BuP, BPA, BPF, BPS, MMP, MiBP, MnBP, MEHP,
MEHHP, MEOHP, MECPP, MBzP, MiNP, MHiNP and MiDP, and
Table I. Names and abbreviations of components
Compound Abbreviation Metabolite Abbreviation Internal standard
Methyl paraben MeP MeP (13C)
Ethyl paraben EtP EtP (d4)
Propyl paraben PrP n-PrP (d4)
n-Butyl paraben n-BuP n-BuP (13C)
Benzyl paraben BzP BzP (d7)
Bisphenol A BPA BPA (13C)
Bisphenol F BPF BPF (13C)
Bisphenol S BPS BPS (13C)
Di-methyl phthalate DMP Mono-methyl phthalate MMP MMP (13C)
Di-ethyl phthalate DEP Mono-ethyl phthalate MEP MEP (13C4)
Di-iso-butyl phthalate DiBP Mono-iso-butyl phthalate MiBP MiBP (d4)
Di-n-butyl phthalate DnBP Mono-n-butyl phthalate MnBP MnBP (13C)
Di-n-hexyl phthalate DnHP Mono-n-hexyl phthalate MnHP MnHP (d4)
Di-(2-ethyl-hexyl) phthalate DEHP Mono-(2-ethylhexyl) phthalate MEHP MEHP (13C)
Mono-(2-ethyl-5-hydroxyhexyl) phthalate MEHHP MEHHP (13C)
Mono-(2-ethyl-5-oxohexyl) phthalate MEOHP MEOHP (13C)
Mono-(2-ethyl-5-carboxypentyl) phthalate MECPP MECPP (13C)
Butylbenzyl phthalate BBzP Mono-benzyl phthalate MBzP MBzP (13C)
Di-iso-nonyl phthalate DiNP Mono-iso-nonyl phthalate MiNP MiNP (13C)
Mono-hydroxy-iso-nonyl phthalate MHiNP MEOHP (13C)
Di-iso-decyl phthalate DiDP Mono-iso-decyl phthalate MiDP MiNP (13C)
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13C analogs for MeP, n-BuP, BPA, BPF, BPS, MMP, MnBP,
MEHP, MEHHP, MEOHP, MECPP, MBzP and MiNP were
obtained from Cambridge Isotopes Laboratory (Tewksbury, MA,
USA). β-glucuronidase originated from E. Coli K 12 (~140 U/mg
at 37°C, at pH 7 with 4-nitrophenyl-β-D-glucuronide as substrate),
sulfatase from Aerobacter aerogenes (10–20 units/mL) and ammo-
nium fluoride (NH4F) were purchased from Sigma Aldrich
(Schnelldorf, Germany). Sodium bicarbonate was obtained from
Merck (Darmstadt, Germany). A 1-butanol HCl was purchased
from Sigma-Aldrich (Schnelldorf, Germany) and methanol, acetoni-
trile, ethyl acetate and formic acid (all LC–MS grade) from Biosolve
(Valkenswaard, The Netherlands). Hydrochloric acid, natrium
hydroxide and buffers of sodium acetate and sodium chloride phos-
phate were provided by the UMCG apothecary (Groningen,
Netherlands). Ultrapure water (18.2MΩ) was obtained from a
Milli-Q system (Millipore, Amsterdam, The Netherlands). For urine
collection, 3 L containers (Becton Dickinson) and 6mL Vacutainer
Tubes (Becton Dickinson) were used, after which samples were
stored in 2.0 mL vials (Sarstedt). All containers and vials that were
used to collect and store the urine samples were tested for potential
phenol and phthalate metabolite contamination before use. Stress
tests were performed: six different containers/vials were filled with
phosphate-buffered saline and incubated for 3 days at 37°C and
subsequently aliquots were analyzed. No traces (<LOD) of the ana-
lyzed compounds were found. All chemicals, solutions, and lab
wares were checked for contamination of phthalate metabolites and
phenols before use. The solvents used for the mobile phase were
checked by running the gradient without performing an injection.
One phthalate was detectable above limit of detection (LOD),
MnHP which was present in the acetonitrile used. This problem
was circumvented by inserting a column just after the mixer of the
UPLC gradient pump (Kinetex 5 μm XB-C18, 50 × 2.1 mm2,
Phenomenex) which delayed the peak of MnHP originating from
the solvent enough, to baseline separate it from MnHP detected in
the sample. Furthermore, all glassware was rinsed and sonicated
with methanol, after which it was allowed to air dry.
Analytical procedures and offline solid phase
extraction
Stock solutions of standards were prepared in methanol at a concen-
tration of 10 μg/mL. A low and high working solution standard mix-
ture (10 and 500 ng/mL) was prepared fresh from the stock solution
in methanol on the day of analysis. The calibration curves consisted
of eight points: 0, 0.5, 1.5, 5.0, 10, 50, 150, 50, 150, 500 and
1,000 ng/mL for the phenols and seven points for the phthalates: 0,
1, 2, 5, 10, 50, 100 and 500 ng/mL for the phthalates. The calibra-
tors were treated the same as the samples, but without adding urine.
The urine volume was replaced with buffer to make sure the same
volume was used in the end. Internal standard working solutions
were prepared in 50% MeOH and concentration was 100 ng/mL
for the phenols and 40 ng/mL for the phthalates. Quality control
(QC) samples were prepared by pooling several urine samples and
were, when necessary, spiked to give two different concentrations.
QC samples were stored in 0.5mL aliquots and stored at −80°C
until use. All urine samples were stored at −80°C until use. Solvent
blank samples consisted of 0.5M natrium acetate. Calibration
curves, QC samples and blank samples were treated as described for
samples below.
For the phenol analysis, 100 μL urine, 25 μL internal standard
solution, 115 μL enzyme mix (0.5M natrium acetate and 10 μL of
20% β-glucuronidase/aryl sulfatase) was added to wells of a 2.0mL
96-deep well plate (Greiner Bio-One). After vortexing for 10min,
the plate was incubated at 37°C for 120min. Successively, 200 μL
methanol was added and vortexed for 1min, where after 300 μL of
the mix (i.e., sample internal standard, buffer, enzyme mix and
methanol) was pipetted on a solid liquid extraction (SLE)-plate
(Biotage). The sample was absorbed and incubated for 5min. A
1,000 μL ethyl acetate was added to each well, and then eluted in a
glass coated 96-well plate (Thermo Fisher Scientific). Elution solvent
was evaporated under nitrogen flow at 60°C, and the residue was
dissolved in 200 μL 50% methanol. After vortexing the samples for
10min, 5 μL was injected on the LC–MS-MS system.
For the phthalate analysis, 100 μL urine, 25 μL internal standard
solution, 115 μL enzyme mix (0.5M sodium acetate pH 5.5, and
10 μL of 20% β-glucuronidase) were added to wells of a 2.0mL 96-
deep well plate (Greiner Bio-One). After vortexing for 10min, the
plate was incubated at 37°C for 120min. After incubation, 150 μL
200mM sodium bicarbonate was added to each well, after which
500 μL ultrapure water was added to the wells. Meanwhile, the solid
phase extraction (SPE)-plate (Strong-anion exchange plate,
Phenomenex) was conditioned with 500 μL methanol and 500 μL
20mM sodium bicarbonate. Samples were extracted and the SPE
plate was subsequently washed with 500 μL 20mM sodium carbon-
ate and 500 μL methanol. Elution was performed in a 96-well glass
coated plate by adding 500 μL 5% formic acid in acetonitrile.
Elution solvent was then evaporated under nitrogen flow at 60°C.
The residue was dissolved in 200 μL 30% acetonitrile and vortexed
for 10min, where after 5 μL was injected on the LC–MS-MS system.
LC–MS-MS method
LC–MS-MS analysis of phenols and phthalates was performed on a
Waters ACQUITY ultra-performance liquid chromatography
(UPLC) system coupled to a Waters XEVO TQ-S triple quadrupole
system using electrospray ionization. UPLC for both assays was per-
formed on a Phenomenex Kinetex® Phenyl-Hexyl 2.1 × 100mm2,
1.7 μm, kept at 40°C. For phenols, mobile phase consisted of A:
0.2mM ammonium fluoride in 10% methanol in water; B: metha-
nol. Gradient elution was performed with a flow of 0.4mL/min and
started at 15% B, with a linear increase to 80% B in 5min.
Gradient was increased to 100% B for 1 min, and was then returned
to 15% B where it was equilibrated for 1 min until the next run,
which resulted in a total runtime of 7min. For phthalates, mobile
phase consisted of A: 0.1% formic acid in 10% acetonitrile; B:
0.1% formic acid in acetonitrile. Gradient elution was performed
with a flow of 0.4mL/min and started at 5% B, with a linear
increase to 65% B in 6.5min. Gradient was increased to 90% B for
1min, and was then returned to 5% B where it was equilibrated for
0.5min until the next run, which resulted in a total runtime of
8min. Target compounds were analyzed in negative electrospray
ionization and selective reaction monitoring mode. For the phenols,
the capillary voltage was 2.0 kV, desolvation temperature 650°C,
cone gas 200 L/h, desolvation gas flow 1,000 L/h, and collision gas
flow 0.2mL/min. For the phthalates, the capillary voltage was
1.5 kV, desolvation temperature 650°C, cone gas 200 L/h, desolva-
tion gas flow 1,000 L/h, and collision gas flow 0.2mL/min. Cone
voltage and collision energies were optimized for all m/z transitions
and are listed in Supplementary Table S1a and b. Quantifier and
qualifier m/z transitions were monitored for all compounds and their
internal standards (Supplementary Table S1a and b). Quantitation
was performed by using the peak-area response ratios of the
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quantifier transitions for the compounds and their respective inter-
nal standards, using Masslynx and Targetlynx software.
Analytical validation
Linearity of the calibration curves was assessed by analyzing the
curves over 10 different days. The variation coefficient of the slope
was calculated, and correlation coefficient were monitored, with a
requirement of a maximal inaccuracy of 15% for the slope and
R2 > 0.99 on each day, respectively. Potential matrix effects have
been checked by mixing two different urine samples containing low
and high concentrations of phenols, parabens and phthalates in dif-
ferent ratios (0, 25, 50, 75, 100%), (R2 > 0.99). Ion suppression
was checked by performing post-column infusion experiments (28).
Intra-assay imprecision was determined by analyzing two urine
pools on the same day in 10 replicates. Inter-assay imprecision was
assessed by measuring two urine pools on 10 different days. Carry
over was determined according CLSI guidelines (EP-10A) (29).
Recovery was estimated by spiking two different urine samples with
two different concentrations (100 and 250 ng/mL for phenols and
50 and 500 ng/mL for phthalates). Recovery percentage was calcu-
lated as follows: [(final concentration – initial concentration)/added
concentration] * 100%. Recovery was considered acceptable within
the range of 100 ± 15%.
The LOD for the phenols, and phthalates was calculated as
3.3 × S0/b, where S0 is the standard deviation of the response and b
the slope of the calibration curve (30). S0 and b were determined by
analyzing quintuplicate sets of the lowest five standards (0.1, 0.2,
0.4, 0.8 and 1.0 ng/mL) in different urine samples (n = 6) with very
low to no phenols or phthalates detectable. Samples were screened
before analysis. The Sy-intercept and slope of the best-fit line of this
plot were used as S0 and b, respectively, and were calculated using
the linear regression function in Graphpad Prism 5.0. The limit of
quantification (LOQ) for each analyte was determined by analyzing
six different samples with progressively lower concentrations of phe-
nols, and phthalates on 6 different days. The LOQ was set where
the imprecision was ≤20% and the signal to noise ratio was >10 on
all 6 days (31).
Method comparison
The two presented methods were validated by analysis of reference
material from the National Institute of Standards & Technology
(NIST) (Gaithersburg, USA), SRM 3672. A NIST-to-Method-ratio
<15% was considered as in excellent accordance, whereas a ratio
15–25% was considered similar, and a ratio >25% as different.
Furthermore parabens, phenols and phthalate metabolites of the
same 24 h urine samples of 40 subjects from the Lifelines cohort
were measured with the present methods and compared with mea-
surements performed by LC–MS-MS methods for phenols, parabens
and phthalates at the Department of Growth and Reproduction,
Rigshospitalet, Copenhagen University Hospital, Denmark (32–34).
Compounds detected in <50% of the samples in one of the facilities
were excluded from comparison. Medians were compared using




LC–MS-MS analysis time per sample was 7min for phenols, and
8min for phthalate metabolites. Chromatograms for analytes are
presented in Figure 1a and b. For phthalates, the phenyl-hexyl col-
umn used was able to separate all metabolites at baseline, also the
structural isomers MiBP and MnBP.
Calibration curves were linear over the calibration range for all
compounds over all 10 days, with correlation coefficients (R2 > 0.99).
The intra-assay coefficients of variability (CV) were ≤10% and inter-
assay CV were ≤12% for all analytes at two QC levels. Recoveries
ranged from 96 to 104% for bisphenols, from 101 to 113% in para-
bens and from 86 to 115% for phthalates (Tables IIa and IIb). No
carry over was detected for any of the compounds in the calibration
range. No significant ion suppression was found at the elution times
of the compounds.
LODs and LOQs are presented in Table III. LODs ranged
between 0.06 ng/mL (n-BuP, BPS) and 0.43 ng/mL (MMP), and was
0.22 ng/mL for BPA. LOQs ranged between 0.5 ng/mL (EtP, MnHP,
MiNP) and 2 ng/mL (MMP, MiBP, MnBP, MEHP, MHiNP), and
was set at 1.4 ng/mL for BPA.
Interlaboratory comparison
Analysis of NIST reference material showed for a majority of the
analytes agreeable: ≤15% for MeP, EtP, BPA, MEP and MnBP; and
≤25% for PrP, n-BuP and MEHP. Only MiBP, MEHHP, MEOHP,
MECPP and MBzP deviated more (84, 62, 27, 34 and 40%, respec-
tively). Data is provided in Supplementary Table SII.
24 h Urine measurements
The concentrations of phenols and phthalate metabolites from forty
24 h urine samples are presented in Table III. The parabens MeP,
and EtP, and the phthalate metabolites MEP, MiBP, MnBP, MEHP,
MEHHP, MEOHP, MECPP and MBzP were detected in ≥93% of
the samples. MMP and MnHP were detected in respectively 48 and
58% of the samples. MHiNP, MiNP and MiDP were not detectable
above LOD in any of the samples measured by the present method.
The parabens n-PrP, n-BuP and BzP were detected in 78, 58 and
15% of the samples, respectively. The bisphenols were detected in
38, 35 and 8% of the samples (BPA, BPF and BPS, respectively).
The results of measurement of these forty 24 h urine samples per-
formed by the present Dutch method were compared with equal
measurements performed by Danish LC–MS-MS methods
(Table III). Both methods were compared for the 17 compounds
measured in the same set of 40 samples by the two laboratories. The
Dutch method detected more samples above LOD for MMP,
whereas the Danish methods measured more cases for MeP, EtP, n-
PrP, n-BuP, BzP, BPA and MiNP. Since BPA, BzP and MiNP were
detected in <50% of the samples by the Dutch method, as was
MMP by the Danish method, these compounds were excluded from
the method comparison. Passing Bablok regression showed slopes
and intercepts of 1.22 and 0.71 (MeP), 1.01 and 0.42 (EtP), 1.13
and 0.20 (n-PrP), 0.95 and 0.22 (n-BuP), 1.15 and −1.84 (MEP),
1.06 and −0.68 (MiBP), 1.18 and 0.47 (MnBP), 1.04 and 0.10
(MEHP), 0.91 and −0.36 (MEHHP), 0.95 and 0.13 (MEOHP),
1.32 and −0.25 (MECPP), and 1.59 and −0.06 (MBzP), respectively
(Figure 2). Supplementary Table S3 displays 95% confidence inter-
vals of slopes and intercepts. Intercepts were similar between both
methods for all EDCs, except for EtP and MEP. Slopes differed for
MeP, MEP, MnBP, MECPP, MEHHP and MBzP, suggesting pro-
portional differences between methods. Yet, when including all sam-
ples >LOD in the analyses, the difference for EtP at intercept
disappeared. All other observed differences remained.
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Figure 1. Representative LC–MS-MS extracted ion chromatograms of a human urine sample fortified with phenols. Concentrations are MeP, 23 ng/mL; BPS,
4.8 ng/mL; EtP, 6.9 ng/mL; BPF, 5.2 ng/mL; PrP, 17 ng/mL; BPA, 7.5 ng/mL; n-BuP, 4.5 ng/mL; BzP, 5.2 ng/mL (A). Representative LC–MS-MS extracted ion chro-
matogram of a human urine sample fortified with phthalate metabolites. Concentrations are MMP, 2.3 ng/mL; MEP, 205 ng/mL; MECPP, 23 ng/mL; MEHHP,
21 ng/mL, MiBP, 30 ng/mL; MnBP, 28 ng/mL; MEOHP, 20 ng/mL; MHiNP, 0.13 ng/mL; MBzP, 34 ng/mL; MnHP, 6.9 ng/mL; MEHP, 16 ng/mL; MiNP, 6.5 ng/mL;
MiDP, 4.8 ng/mL (B).








roningen user on 12 February 2020
Discussion
In this study we developed and validated two LC–MS-MS methods
which are able to measure 5 parabens, 3 bisphenols and 13 different
metabolites of eight phthalates.
By implementing the measurements of both parabens and bisphe-
nols in one run, as well as using UPLC, we reduced the LC–MS-MS
runtime to 7min for phenols and 8min for phthalates. This is much
shorter than other methods, which report retention times from 8.9
to 17min for phenol methods (13, 36, 37), and 10.2–27min for
phthalate methods (37–40). Although the runtime was reduced,
chromatographic resolution was more than sufficient to separate iso-
mers, which is important, especially in phthalate analysis. MiBP and
MnBP were separated at baseline by using acetonitrile as eluent,
instead of methanol. Furthermore, sensitivity of the phenol analysis
was increased by the addition of ammonium fluoride in the mobile
phase. It was previously shown that ammonium fluoride enhances
ionization of estrogens, and this is also the case for the analysis of
phenols with electrospray ionization, ranging from 12 times for
MeP to 70 times for BPA with respect to peak area (supplemental
Figure 1) (41). As there is 200 μL of sample available for analysis at
the end of the SPE of which only 5 μL is injected, we tried to further
improve chromatographic resolution by increasing the injecting vol-
ume. Yet neither method showed a better signal-to-noise ratio when
injecting a volume of 10 μL, the maximum loading volume.
For method validation, we measured NIST reference material
and found that 5 out of the 13 compared analytes were in excellent
accordance (i.e., NIST-to-Method-ratio <15%) to the concentra-
tions given by NIST (i.e., MeP, EtP, BPA, MEP and MnBP), whereas
PrP, n-BuP and MEHP showed similar values (i.e., NIST-to-
Method-ratio: 15–25%). Yet the concentrations measured for the
phthalates MiBP, MEHHP, MEOHP, MECPP and MBzP showed
differences (i.e., NIST-to-Method-ratio >25%), which might be due
to the difference in analytical methods and calibration. The levels of
EDCs in the NIST standard were established using a GC–MS-MS
method for BPA and online SPE-LC–MS-MS for parabens and
phthalates, whereas the present method uses offline SPE in combina-
tion with UPLC–MS-MS (42). Although Sigma-Aldrich states the
NIST samples are suitable for HPLC, this is not known for UPLC.
Notably, for the four out of five phthalates (i.e., MiBP, MEHHP,
MEOHP and MECPP) which showed the largest differences, our
method measures lower concentrations, which could indicate better
separation of possible interferences, due to higher resolution of
UPLC in comparison to HPLC.
Furthermore, we compared measurements of forty 24 h urine
samples from our present Dutch UPLC–MS-MS methods with estab-
lished Danish LC–MS-MS methods (32–34). These methods show
very similar results. Discrepancies found in intercept for EtP and
MEP suggest systematic differences between methods. Yet, when
including samples measured above LOD by the Dutch method this
difference disappears. Although samples with a concentration
<LOQ cannot be accurately quantified, this implies that this system-
atic difference is due to the different cut-off levels used. Differences
in slope were minor (9–22%) for all compounds but for MECPP
and MBzP, and can be explained by a few outliers at high concen-
trations, and minor differences in calibration. Additionally, as
phthalate monoesters are found in a wide variety of products, analy-
sis is prone to variation due to possible external contamination (43).
Yet MECPP is a secondary metabolite for DEHP, and therefore has
to be metabolized in the human body, which makes external con-
tamination not possible (44). By thoroughly checking all materials
Table IIa. Method validation for phenols: intra- and inter-assay controls and recoveries
Intra-assay Recovery Inter-assay
Mean SD CV (%) Mean (%) Mean SD CV (%)
100 ng/mL 250 ng/mL
MeP
Low 22.7 0.6 3 101 102 22.4 1.4 6
High 166 5.3 3 105 104 165 4.7 3
EtP
Low 6.30 0.3 5 103 102 6.40 0.4 6
High 177 6.2 4 110 107 178 4.5 3
n-PrP
Low 14.1 0.6 4 106 106 15.9 1.0 6
High 151 6.3 4 113 110 166 4.1 3
n-BuP
Low 4.50 0.2 5 102 102 4.60 0.2 5
High 135 5.8 4 102 101 139 3.4 2
BzP
Low 4.90 0.1 3 109 106 4.80 0.5 10
High 155 4.4 3 106 102 155 6.8 4
BPA
Low 6.20 0.5 8 101 100 6.30 0.8 12
High 125 3.0 2 96 97 129 6.8 5
BPF
Low 4.70 0.4 9 99 100 5.30 0.5 9
High 149 5.9 4 101 101 145 6.7 5
BPS
Low 4.70 0.2 4 103 103 4.70 0.4 8
High 145 5.6 4 104 103 146 2.6 2
Names and abbreviations of all analytes are shown in Table I. SD, standard deviation; CV, coefficient of variability.
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used for contamination, as well as including blank samples in every
analysis, potential contamination is closely monitored and mini-
mized. For one urine sample, we detected consistently lower concen-
trations in multiple phthalate measurements (i.e., MEP, MEOHP,
MEHP, MEHHP, MECPP), suggesting a problem at sample level
(e.g., sample contamination), rather than in the LC–MS-MS method.
In a comparison of median concentrations of compounds measured
by both countries, the Dutch methods reported significantly higher
concentrations for one paraben and four phthalate metabolites (i.e.,
MeP, MEP, MnBP, MECPP, MBzP). As this could be explained by
using a higher LOQ as cut-off in the Dutch method, Passing
Babloks were compared using all samples measured above LOD by
the Dutch method. This resulted in similar outcomes for all but EtP,
implying that the difference between methods is due to a higher cut-
off used in the Dutch method.
As EDCs have only recently been introduced in human biomoni-
toring, interlaboratory comparisons are often difficult. In a recent
study, the European (DEMO)COPHES project aimed to develop
analytical methods for the human biomonitoring of environmental
pollutants in urine and generate comparable data across Europe
(43). This study included five phthalate metabolites of which three
are also included in this study, and BPA. Yet even the laboratories
chosen as reference because of their expertise showed a relatively
high interlaboratory imprecision (relative standard deviations rang-
ing from 6 to 39% for phthalates, and 11 to 20% for BPA). Of the
participating laboratories, only 37 and 38% were able to qualify for
the measurements of phthalates and BPA, respectively, by passing
one interlaboratory comparison investigation and one external qual-
ity assessment scheme exercise. Taking the above results into
account our results show a high level of agreement with the NIST
and Danish method.
The samples investigated were collected between 2008 and
2010, after which they have been stored at −80°C for a maximum
of eight years before analyses. During this time, EDCs of interest
Table IIb.Method validation for phthalates: intra- and inter-assay controls and recoveries
Intra-assay Recovery Inter-assay
Mean SD CV (%) Mean (%) Mean SD CV (%)
50 ng/mL 500 ng/mL
MMP
Medium 7.50 0.6 8 105 97 6.00 0.6 10
High 48.3 2.7 6 101 94 44.4 2.9 7
MEP
Low 150 3.9 3 113 93 151 14 9
High 208 5.6 3 94 86 196 13 7
MiBP
Low 34.4 1.9 6 103 101 29.0 1.8 6
High 167 7.9 5 115 96 152 19 12
MnBP
Low 27.7 1.2 4 111 102 27.4 1.7 6
High 161 3.4 2 115 88 164 7.1 4
MnHP
Low 4.80 0.2 4 105 95 4.80 0.2 4
High 46.1 1.0 2 104 93 45.0 2.0 5
MEHP
Low 10.7 0.7 7 103 95 11.1 0.7 7
High 52.1 2.1 4 99 94 53.8 2.2 4
MEHHP
Low 16.0 0.4 2 99 102 15.3 1.1 7
High 113 2.2 2 104 97 111 4.6 4
MEOHP
Low 13.6 0.3 3 104 96 13.8 0.7 5
High 107 4.0 4 113 96 109 5.0 5
MECPP
Low 17.9 0.7 4 103 99 18.0 1.1 6
High 116 3.0 3 105 97 119 7.6 6
MBzP
Low 10.6 1.1 10 99 100 10.8 0.7 6
High 91.7 8.4 9 93 100 88.5 5.9 7
MiNP
Low 5.50 0.2 3 111 92 5.30 0.2 4
High 54.7 1.7 3 100 89 54.6 2.0 4
MHiNP
Low ND ND ND
High ND ND ND
MiDP
Low 4.50 0.2 4 110 98 4.60 0.3 7
High 45.5 2.0 4 106 97 50.4 3.8 8
Names and abbreviations of all analytes are shown in Table I. SD, standard deviation; CV, coefficient of variability; ND, not determined.
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Table III. Urinary levels of EDCs measured by new methods and established method at Department of Growth and Reproduction, Rigshospitalet, Copenhagen
Dutch facility (ng/mL) Danish facility (ng/mL)
LOD N > LOD (%) LOQ N > LOQ (%) mean q25 q50 q75 max LOD N > LOD (%) mean q25 q50 q75 max
Parabens
MeP 0.14 39 (98) 1 38 (95) 58.7 5.32 53.3 79.5 200 0.08 40 (100) 47.8 8.40 37.4 63.7 165
EtP 0.09 37 (93) 0.5 31 (78) 8.94 0.73 3.68 10.3 54.5 0.04 40 (100) 8.39 0.63 3.18 8.83 56.5
n-PrP 0.07 31 (78) 1 25 (63) 20.0 0.09 3.72 29.4 141 0.05 37 (93) 11.2 0.33 1.87 15.0 79.0
n-BuP 0.06 23 (58) 1 14 (35) 2.39 <LOD 0.15 2.05 19.3 0.05 26 (65) 2.4 <LOD 0.16 2.03 20.8
BzP 0.07 6 (15) 1 0 (0) 0.05 <LOD <LOD <LOD 0.48 0.05 15 (38) 0.07 <LOD <LOD 0.02 0.52
Bisphenols
BPA 0.22 15 (38) 1.4 8 (20) 1.47 <LOD <LOD 1.22 27.3 0.12 40 (100) 2.06 0.95 1.69 2.34 14.3
BPF 0.23 14 (35) 1.5 7 (18) 1.40 <LOD <LOD 0.93 27.3
BPS 0.06 3 (8) 0.8 1 (3) 0.11 <LOD <LOD <LOD 3.28
Phthalates
MMP 0.43 19 (48) 2 7 (18) 1.06 <LOD <LOD 1.31 7.28 0.53 3 (8) 0.32 <LOD <LOD <LOD 7.32
MEP 0.35 40 (100) 1 40 (100) 114 18.9 28.8 169 965 0.79 40 (100) 103 17.2 28.4 169 767
MiBP 0.33 40 (100) 2 40 (100) 34.2 13.3 21.1 36.1 196 0.44 40 (100) 33.3 13.2 21.1 35.5 199
MnBP 0.22 40 (100) 2 40 (100) 35.7 13.1 18.2 33.6 307 0.68 40 (100) 30.7 11.3 17.6 27.0 273
MnHP 0.07 23 (58) 0.5 0 (0) 0.10 <LOD 0.08 0.18 0.47 0.33 1 (3) 0.4 <LOD <LOD <LOD <LOD
MEHP 0.12 40 (100) 2 25 (63) 3.30 1.54 2.54 3.38 14.0 0.42 40 (100) 3.16 1.53 2.34 3.44 13.5
MEHHP 0.11 40 (100) 1 40 (100) 13.5 5.66 8.36 15.6 52.7 0.44 40 (100) 15.7 7.18 10.5 18.5 62.5
MEOHP 0.09 40 (100) 1 40 (100) 8.84 3.72 5.58 9.71 32.5 0.46 40 (100) 9.44 3.71 6.39 11.5 38.6
MECPP 0.25 40 (100) 1 40 (100) 12.8 5.34 10.2 15.0 59.2 0.28 40 (100) 10.0 4.51 7.79 11.9 47.8
MBzP 0.22 40 (100) 1 40 (100) 8.63 2.89 4.8 10.8 41.6 0.50 40 (100) 5.47 1.96 3.03 6.66 28.5
MiNP 0.10 0 (0) 0.5 0 (0) <LOD <LOD <LOD <LOD 0.39 13 (33) 0.28 <LOD <LOD 0.48 2.17
MHiNP 0.29 0 (0) 2 0 (0) <LOD <LOD <LOD <LOD
MiDP 0.31 0 (0) 1 0 (0) <LOD <LOD <LOD <LOD
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could have been subject to degradation. Parabens, BPA, and phthal-
ate metabolites are described to remain stable for at least six months
to one year at −70°C (45, 46). Another study shows that, although
for a timespan of one week, additional preservatives do not improve
stability (47). Yet, degradation over multiple years has not yet been
investigated. Various freeze-thaw cycles may negatively influence the
quality of the samples. In this study, both facilities received their
own aliquot. Therefore, samples did not have to be thawed to be
distributed, and were thawed twice in total (i.e., for phthalate
method, for phenol method) at both facilities.
Compared to another Dutch study which analyzed exposure to
EDCs, some of the phthalate metabolites measured were comparable
(median (ng/mL) [inter-quartile range]: MiBP: 21 [22,83] versus 22
[36,36]; MnBP: 18 [20,55] versus 16 [24,21]), although in general
we measured lower concentrations in our LifeLines cohort (12).
Differences could be explained by the difference in study population
(pregnant women versus general population), as several of these
EDCs have sex-specific concentrations (48). Also, the study location
differed (Rotterdam versus the north of the Netherlands), which
could influence the consumer products used. Although differences in
Figure 2. Passing Bablok regression plots comparing parabens (A) and phthalate metabolites (B) in 40 human urine samples measured by the present method
(y-axis) and by LC–MS-MS methods at Department of Growth and Reproduction, Rigshospitalet, Copenhagen (x-axis). The line of identity (x = y) represents a
perfect match.
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EDC exposure between urban, metropolitan and rural areas have
been shown in a study conducted in Italy, a Danish study showed
similar exposure to EDCs (49, 50). Lastly, the method of analysis
was different. Although Philips et al. (12) use a validated method,
methods have not been compared. Furthermore, the Rotterdam
study collected urine samples in 2004 and 2005, whereas Lifelines
Figure 2. Continued
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urine samples were collected between 2008 and 2010. Changes in
regulation, consumer awareness or the introduction of alternatives
have led to a change of EDC production and exposure through
time. This has been shown in different studies reporting change in
EDC exposure through time (i.e., calendar year). For example, high-
er concentrations of BPF, BPS, MiBP and DiNP have been detected
over the years, whereas BPA, MnBP, MBzP and DEHP concentra-
tions have decreased over time (22, 51–53). Furthermore, the
method of urine collection (spot urine versus 24 h urine) may play
an important factor. Although spot-urine samples are a good esti-
mate for population studies, 24 h urine samples are required for
assessing individual daily exposure due to the quick metabolism and
excretion of these compounds (54, 55). Lastly, due to high inter-
individual variation in concentrations, epidemiological studies with
large sample sizes are required. Keeping in mind the limited sample
size of this study comparisons should be made with caution.
In conclusion, we showed that our newly developed fast high
throughput UPLC–MS-MS methods are capable of reproducible and
sensitive analysis of 5 parabens and 3 bisphenols, and 13 different
metabolites of 8 different phthalates in human urine. Sensitivity of
the phenol method including both bisphenols and parabens was
increased by using ammonium fluoride in the mobile phase.
Supplementary data
Supplementary material is available at Journal of Analytical Toxicology
online.
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